Barrington Research reaffirmed their outperform rating on shares of U.S. Physical Therapy (NYSE:USPH – Free Report) in a research note issued to investors on Friday, Benzinga reports. Barrington Research currently has a $108.00 price objective on the stock.
Separately, StockNews.com upgraded shares of U.S. Physical Therapy from a sell rating to a hold rating in a research report on Wednesday, August 21st.
Get Our Latest Stock Report on U.S. Physical Therapy
U.S. Physical Therapy Price Performance
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). The firm had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.76 earnings per share. As a group, research analysts expect that U.S. Physical Therapy will post 2.51 EPS for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy’s payout ratio is 143.09%.
Insider Activity at U.S. Physical Therapy
In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin purchased 2,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were purchased at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director Kathleen A. Gilmartin purchased 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.
Institutional Trading of U.S. Physical Therapy
A number of institutional investors have recently added to or reduced their stakes in the stock. Conestoga Capital Advisors LLC lifted its position in U.S. Physical Therapy by 1.0% in the 1st quarter. Conestoga Capital Advisors LLC now owns 15,075 shares of the company’s stock worth $1,702,000 after buying an additional 145 shares during the last quarter. Texas Permanent School Fund Corp boosted its position in shares of U.S. Physical Therapy by 1.3% during the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock valued at $1,480,000 after purchasing an additional 170 shares in the last quarter. First Horizon Advisors Inc. grew its position in shares of U.S. Physical Therapy by 18.6% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after buying an additional 186 shares during the period. Louisiana State Employees Retirement System grew its holdings in U.S. Physical Therapy by 2.7% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock worth $702,000 after purchasing an additional 200 shares during the period. Finally, ProShare Advisors LLC increased its position in U.S. Physical Therapy by 7.4% during the 1st quarter. ProShare Advisors LLC now owns 3,002 shares of the company’s stock valued at $339,000 after buying an additional 206 shares in the last quarter.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More
- Five stocks we like better than U.S. Physical Therapy
- What is the S&P/TSX Index?
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Using the MarketBeat Stock Split Calculator
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.